Table 2.
Sexual dimorphisms in mice lacking enzymes that participate in formation of bile acids with clinical phenotypes in humans (differences between sexes not considered in these studies)
Bile Acid Synthetic Enzyme | Phenotype in knockout in terms of BAs & cholesterol | Human phenotype when gene is mutated |
---|---|---|
CYP7A1 | Lithogenic composition of gallstones with increased dietary cholesterol in females [30] | Statin-resistant hypercholesterolemia [28] |
BA pool - larger in females [30] | ||
BA pool composition - higher CA in females [30] | ||
Hepatic cholesterol accumulation with increased dietary cholesterol in females (males not reported) [31] | 94% reduction in fecal BA excretion [28] | |
Maternal consumption of high fat diet results in male offspring with lower expression than females [33] | Premature atherosclerosis [28] | |
CYP8B1 | BA pool increases in male more dramatically than in females [3] | |
Greater compensatory response by CYP7A1 in female knockout, resulting in increased CDCA [3] | ||
CYP27A1 | Sex differences not reported [55, 59] | Cerebrotendinous xanthomatosis [55] |
Vascular and muscle cholesterol deposition [60] | ||
ARK1D1 | Higher hepatic BA concentration and lean phenotype in males [69] | |
CYP3A4 | Sex differences not reported in genome-edited rats [75] |